View Clinical Trial (Medical Research Study)

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma - NCT00461812-21224(Clinical Trial 168573)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Baltimore
State:  
MD
Zip Code: 21224
Conditions: Asthma
Purpose: The research hypothesis for the proposed study asks the question, can Asmanex® demonstrate comparable anti-inflammatory therapeutic efficacy to the combination product, Advair® in control of mild persistent asthma? The purpose is to demonstrate that the anti-inflammatory protection afforded by monotherapy with an inhaled steroid (Asmanex®) is comparable to combination therapy with Advair® 100/50, when measured by this standard methodology (methacholine bronchoprovocation) in subjects with mild persistent asthma.
Study summary:
Criteria: Inclusion Criteria: - subjects 18 to 65 years of age - a >2 year history of asthma - FEV1 > 80% for subjects currently using Advair®. Exclusion Criteria: - severe asthma - current smokers - pregnant or breast-feeding women - other chronic significant illnesses
Study is available at: Johns Hopkins Asthma and Allergy Center
Baltimore, MD 21224
United States

Primary Contact:
Arouna P Khattignavong, MD
Email: akhatti1@jhmi.edu
Phone: 410-550-2184
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.